Univadis Practice Changers: FDA’s opioid deprescribing guidelines

Update: 2019-07-08

Description

Yael Waknine of Univadis speaks with Dr. Neil Skolnik, Professor of Family and Community Medicine at Sidney Kimmel Medical College, about the FDA's opioid deprescribing guidelines and why tapering the medications has to be done as carefully as prescribing them in the first place.

Comments

In Channel

Univadis Practice Changers: NOACs vs VKAs in Afib with early-stage CKD

2019-09-1603:22

Univadis Practice Changers: Dulaglutide not just for T2D with established CVD

2019-09-1405:05

Univadis Practice Changers: Lifestyle vs genetics in dementia risk

2019-09-0903:59

Univadis Practice Changers: FDA approves first nasal glucagon for severe hypoglycemia

2019-09-0203:20

Univadis Practice Changers: Benefit of exercise after 40

2019-08-2604:14

Univadis Practice Changers: New USPSTF recommendations for PrEP

2019-08-1905:45

Univadis Practice Changers: Canagliflozin for diabetic kidney disease

2019-08-1204:34

Univadis Practice Changers: How to cut heart failure risk in half

2019-08-0703:18

Univadis Practice Changers: Stroke/TIA and clopidogrel + aspirin

2019-08-0503:34

Univadis Practice Changers: 2019 measles outbreak

2019-07-2903:42

Univadis Practice Changers: Trial shows efficacy of dulaglutide

2019-07-2205:24

Univadis Practice Changers: USPSTF recommends significant changes to HIV screening

2019-07-2205:23

Univadis Practice Changers: FDA approves oral hydrogel therapy

2019-07-1505:32

Univadis Practice Changers: FDA’s opioid deprescribing guidelines

2019-07-0803:47

Univadis Practice Changers: Pregnancy and measles

2019-07-0103:55

Univadis Practice Changers: Effect of resistance training on hot flashes

2019-06-2503:59

Univadis Practice Changers: Sports in adolescence and mental health in adulthood

2019-06-2503:39

Univadis Practice Changers: Health and economic consequences of physician burnout

2019-06-2505:11

Univadis Practice Changers: Findings of 30-year study on lifestyle interventions for prediabetes

2019-06-2505:01

00:00

Univadis Practice Changers: FDA’s opioid deprescribing guidelines

#box-pro-ellipsis-17617037810870{-webkit-line-clamp:2;}Univadis Practice Changers: FDA’s opioid deprescribing guidelines

Univadis Practice Changers: FDA’s opioid deprescribing guidelines

Univadis Practice Changers: FDA’s opioid deprescribing guidelines